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Letter to the Editor
Aspects of UGT2B15 in the Human
To the Editor,
In their interesting and important new article on human
UGT2B15, Divakaran et al. (2014) are to be congratulated for their
determination to go beyond transcripts and to measure protein
levels in a meticulous way.
These authors report an interesting post-natal sex difference
in UGT2B15, with males expressing higher levels in the liver
than females, as previously demonstrated by Court (2010). In
our study (O’Shaughnessy et al., 2013), which was not men-
tioned in the Divakaran et al. (2014) publication, we observed no
significant difference in hepatic UGT2B15 transcript between
male and female fetuses at 11–21 weeks of gestation. This is de-
spite the expression of androgen receptor (AR) transcript and
protein in the human fetal liver and the plentiful circulating tes-
tosterone in the male human fetus at this time (O’Shaughnessy
et al., 2007; 2013). It is very interesting that, despite the well-
known sex-differentiating drive during the second trimester,
this important hepatic enzyme does not show a sex difference
until post-natal life. This later developmental onset of a sex dif-
ference in UGT2B15 may have important therapeutic implica-
tions. Furthermore, the fact that we (O’Shaughnessy et al.,
2013) observed no effect of maternal smoking on fetal
hepatic UGT2B15 expression (unlike UGT2B17 expression) does
not mean that in utero exposure to cigarette smoke chemicals
might not also perturb programming of post-natal UGT2B15.
Unfortunately, there does not appear to be any existing litera-
ture on the effects of prenatal cigarette smoke exposure on
these enzymes in the human liver in childhood or adult life.
Taken together, we now know from three well-powered
studies that UGBTB15 expression is liver-predominant and
climbs steadily from 5 weeks of gestation onwards (Divakaran
et al., 2014; Ekstrom et al., 2013; O’Shaughnessy et al., 2013), in-
dicative of an important role in fetal and then adult hepatic
function. Furthermore, because of its role in fetal programming,
a better understanding of the development of the human liver
more generally, and its response to adverse exposure through
maternal recreational drugs (including cigarettes and alcohol),
is critical. This knowledge will be important in supporting popu-
lation-based studies relating the in utero environment to subse-
quent adult health.
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